BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32933378)

  • 1. Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an
    Mutlu O; Ugurel OM; Sariyer E; Ata O; Inci TG; Ugurel E; Kocer S; Turgut-Balik D
    J Biomol Struct Dyn; 2022 Feb; 40(2):918-930. PubMed ID: 32933378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses.
    Elkarhat Z; Charoute H; Elkhattabi L; Barakat A; Rouba H
    J Biomol Struct Dyn; 2022 Jan; 40(1):361-374. PubMed ID: 32873176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP.
    Biswal M; Diggs S; Xu D; Khudaverdyan N; Lu J; Fang J; Blaha G; Hai R; Song J
    Nucleic Acids Res; 2021 Jun; 49(10):5956-5966. PubMed ID: 33999154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitors derived from the nsp7 and nsp8 cofactors of nsp12 targeting different substrate binding sites of nsp12 of the SARS-CoV-2.
    Jena NR; Pant S
    J Biomol Struct Dyn; 2023 Jul; ():1-13. PubMed ID: 37434315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
    Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T
    J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.
    Martin R; Li J; Parvangada A; Perry J; Cihlar T; Mo H; Porter D; Svarovskaia E
    Antiviral Res; 2021 Apr; 188():105033. PubMed ID: 33549572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility.
    Kim SM; Kim EH; Casel MAB; Kim YI; Sun R; Kwak MJ; Yoo JS; Yu M; Yu KM; Jang SG; Rollon R; Choi JH; Gil J; Eun K; Kim H; Ensser A; Hwang J; Song MS; Kim MH; Jung JU; Choi YK
    Cell Rep; 2023 Sep; 42(9):113077. PubMed ID: 37676771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-protein interaction of RdRp with its co-factor NSP8 and NSP7 to decipher the interface hotspot residues for drug targeting: A comparison between SARS-CoV-2 and SARS-CoV.
    Sarma H; Jamir E; Sastry GN
    J Mol Struct; 2022 Jun; 1257():132602. PubMed ID: 35153334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.
    Wilamowski M; Hammel M; Leite W; Zhang Q; Kim Y; Weiss KL; Jedrzejczak R; Rosenberg DJ; Fan Y; Wower J; Bierma JC; Sarker AH; Tsutakawa SE; Pingali SV; O'Neill HM; Joachimiak A; Hura GL
    Biophys J; 2021 Aug; 120(15):3152-3165. PubMed ID: 34197805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
    Wang Q; Wu J; Wang H; Gao Y; Liu Q; Mu A; Ji W; Yan L; Zhu Y; Zhu C; Fang X; Yang X; Huang Y; Gao H; Liu F; Ge J; Sun Q; Yang X; Xu W; Liu Z; Yang H; Lou Z; Jiang B; Guddat LW; Gong P; Rao Z
    Cell; 2020 Jul; 182(2):417-428.e13. PubMed ID: 32526208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19.
    Aleebrahim-Dehkordi E; Ghoshouni H; Koochaki P; Esmaili-Dehkordi M; Aleebrahim E; Chichagi F; Jafari A; Hanaei S; Heidari-Soureshjani E; Rezaei N
    J Mol Struct; 2023 Sep; 1287():135642. PubMed ID: 37131962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2.
    Lima Neto JX; Bezerra KS; Barbosa ED; Araujo RL; Galvão DS; Lyra ML; Oliveira JIN; Akash S; Jardan YAB; Nafidi HA; Bourhia M; Fulco UL
    Front Mol Biosci; 2023; 10():1325588. PubMed ID: 38304231
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular modelling and structure-activity relationship of a natural derivative of
    Ayipo YO; Ahmad I; Najib YS; Sheu SK; Patel H; Mordi MN
    J Biomol Struct Dyn; 2023 Mar; 41(5):1959-1977. PubMed ID: 35037841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
    Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
    mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopeptides against COVID-19 RNA-dependent RNA polymerase using molecular docking.
    Xia B; Luo M; Pang L; Liu X; Yi Y
    Biomed J; 2021 Dec; 44(6 Suppl 1):S15-S24. PubMed ID: 34871815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
    Courouble VV; Dey SK; Yadav R; Timm J; Harrison JJEK; Ruiz FX; Arnold E; Griffin PR
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1618-1630. PubMed ID: 34121407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach.
    Singh SK; Upadhyay AK; Reddy MS
    3 Biotech; 2021 Feb; 11(2):93. PubMed ID: 33520579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.
    Reshamwala SMS; Likhite V; Degani MS; Deb SS; Noronha SB
    J Med Virol; 2021 Jul; 93(7):4616-4619. PubMed ID: 33433004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-dependent RNA polymerase of SARS-CoV-2 regulate host mRNA translation efficiency by hijacking eEF1A factors.
    Gan H; Zhou X; Lei Q; Wu L; Niu J; Zheng Q
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166871. PubMed ID: 37673357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Kuzikov M; Reinshagen J; Wycisk K; Corona A; Esposito F; Malune P; Manelfi C; Iaconis D; Beccari A; Tramontano E; Nowotny M; Windshügel B; Gribbon P; Zaliani A
    Virus Res; 2024 May; 343():199356. PubMed ID: 38490582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.